Development of a benzopyran-containing androgen receptor antagonist to treat antiandrogen-resistant prostate cancer.
Department of Chemistry, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul 151-747, Korea.
Sangmi
S
Oh
Hye Jin
HJ
Nam
Jongmin
J
Park
Sung Hee
SH
Beak
Seung Bum
SB
Park
D000726:Androgen Antagonists / Q000138:chemical synthesis / Q000737:chemistry* / Q000627:therapeutic use; D059002:Androgen Receptor Antagonists; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000627:therapeutic use; D001578:Benzopyrans / Q000138:chemical synthesis / Q000737:chemistry* / Q000627:therapeutic use; D002460:Cell Line; D006801:Humans; D008297:Male; D008968:Molecular Conformation; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011944:Receptors, Androgen / Q000378:metabolism
D000726:Androgen Antagonists; D059002:Androgen Receptor Antagonists; D000970:Antineoplastic Agents; D001578:Benzopyrans; D011944:Receptors, Androgen